Such nanobodies have proven useful in the identification of P2X7-expressing cells in tissues and organs from rodents [71,72] and humans [73] and as potential biologics to attenuate disease, as already shown in mouse models of inflammatory [70] and neurological [74] disorders as well as cancer [75]. This evidence concerns the gene P2RX7 and cancer.